Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Platelet Disorders”

1,903 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,903 results

Not applicableStudy completedNCT03306017
What this trial is testing

Effects of Left Ventricular Assist Device Implantation on the Phenotype of Blood Platelets and Leucocytes

Who this might be right for
Cardiac Insufficiency
University Hospital, Toulouse 4
Testing effectiveness (Phase 2)UnknownNCT04715360
What this trial is testing

Management of Cytokine Storms in Severe COVID-19 Patients With Autologous Activated Platelet-rich Plasma Therapy

Who this might be right for
Covid19Sars-CoV-2 InfectionARDS, Human+1 more
Hayandra Peduli Foundation 30
Not applicableStudy completedNCT01843361
What this trial is testing

Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study

Who this might be right for
Ischemic Stroke
Ruhr University of Bochum 159
Not applicableLooking for participantsNCT05823376
What this trial is testing

Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease

Who this might be right for
Platelet Recovery After Umbilical Cord Blood Transplantation
Anhui Provincial Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT02566603
What this trial is testing

PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Protalex, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00632242
What this trial is testing

ARC1779 Injection in Patients With Von Willebrand Factor-Related Platelet Function Disorders

Who this might be right for
Purpura, Thrombotic ThrombocytopenicVon Willebrand Disease Type-2b
Archemix Corp. 28
Not applicableWithdrawnNCT02663648
What this trial is testing

Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders

Who this might be right for
Myeloproliferative DisordersPolycythemia VeraEssential Thrombocythemia+2 more
Shandong University
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Large-scale testing (Phase 3)Study completedNCT02506140
What this trial is testing

Platelet Reactivity in Acute Non-disabling Cerebrovascular Events

Who this might be right for
StrokeIschemic Attack, Transient
Beijing Tiantan Hospital 675
Testing effectiveness (Phase 2)Ended earlyNCT00467831
What this trial is testing

Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome

Who this might be right for
Hermansky-Pudlak Syndrome (HPS)Pulmonary FibrosisOculocutaneous Albinism+2 more
National Human Genome Research Institute (NHGRI) 3
Testing effectiveness (Phase 2)Study completedNCT00946270
What this trial is testing

Pomalidomide for Myelofibrosis Patients

Who this might be right for
Polycythemia VeraThrombocythemia
M.D. Anderson Cancer Center 70
Not applicableStudy completedNCT02368340
What this trial is testing

A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis

Who this might be right for
Hermansky Pudlak Syndrome
Vanderbilt University 55
Large-scale testing (Phase 3)Study completedNCT01259856
What this trial is testing

Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Who this might be right for
High Risk Polycythemia VeraHigh Risk Essential Thrombocythemia
Ronald Hoffman 168
Testing effectiveness (Phase 2)Active Not RecruitingNCT04262141
What this trial is testing

IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV)

Who this might be right for
Essential ThrombocythemiaPolycythemia Vera
Terrence J Bradley, MD 4
Large-scale testing (Phase 3)Study completedNCT00116688
What this trial is testing

Open Label Extension Study of Romiplostim (AMG 531) in Thrombocytopenic Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Who this might be right for
ThrombocytopeniaIdiopathic Thrombocytopenic Purpura
Amgen 313
Not applicableStudy completedNCT02539186
What this trial is testing

The Effect of Platelet Rich Plasma for Carpal Tunnel Syndrome

Who this might be right for
Carpal Tunnel Syndrome
Tri-Service General Hospital 60
Large-scale testing (Phase 3)Study completedNCT05226546
What this trial is testing

Effectiveness and Safety of Platelet Rich Plasma (PRP) on Persistent Olfactory Dysfunction Related to COVID-19

Who this might be right for
AnosmiaCOVID-19
Centre Hospitalier Universitaire Saint Pierre 56
Not applicableActive Not RecruitingNCT06870851
What this trial is testing

Predicting Platelet Count From Viscoelastic Testing

Who this might be right for
Thrombocytopenia
Kepler University Hospital 2,500
Testing effectiveness (Phase 2)Looking for participantsNCT07136857
What this trial is testing

Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)

Who this might be right for
Glanzmann Thrombasthenia
Emory University 6
Load More Results